38.6 Percent of 9- to 17-Year-Olds Have Received at Least One HPV Vaccine Dose
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Feb. 14, 2024 -- In 2022, 38.6 percent of children aged 9 to 17 years had received one or more doses of human papillomavirus (HPV) vaccine, according to a February data brief published by the National Center for Health Statistics.
Maria A. Villarroel, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used parent-reported data from the 2022 National Health Interview Survey to describe the percentage of children ages 9 to 17 years who had received at least one dose of the HPV vaccine.
The researchers found that in 2022, 38.6 percent of children aged 9 to 17 years had received one or more doses of HPV vaccine. The likelihood of receiving one or more HPV vaccine doses was higher for children with private health insurance compared with those with Medicaid coverage, those with other government coverage, and those without insurance (41.5 percent versus 37.0, 30.2, and 20.7 percent, respectively). Among those with disability, the percentage of children who had received at least one HPV vaccine dose was higher. Compared with children living in nonmetropolitan areas, those living in central metropolitan areas, large fringe metropolitan areas, and medium and small metropolitan areas were more likely to have received one or more doses of HPV vaccine (30.0 percent versus 39.4, 41.1, and 39.4 percent, respectively).
"Vaccination coverage increased with child's increasing age, parental education, and family income," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
At-School Vaccination Boosts HPV Vaccination Coverage
THURSDAY, May 30, 2024 -- At-school vaccination may be a useful tool to increase human papillomavirus (HPV) vaccination coverage among adolescents, according to a study published...
Primary HPV Screening Intervals Could Be Extended
FRIDAY, May 24, 2024 -- Primary human papillomavirus (HPV) screening intervals could be extended, with the risk for cervical precancer or worse (CIN2+) eight years after negative...
ASCO: HPV Vaccination Positively Affecting More Than Just Cervical Cancer Risk
THURSDAY, May 23, 2024 -- Human papillomavirus (HPV) vaccination is associated with reduced odds of several types of HPV-related cancers, not just cervical cancer, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.